Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China · Delayed Price · Currency is CNY 20.57
+0.10 (0.49%)
Sep 30, 2025, 3:00 PM CST
SHA:605266 Revenue
Jianzhijia Pharmaceutical Chain Group had revenue of 2.16B CNY in the quarter ending June 30, 2025, a decrease of -0.40%. This brings the company's revenue in the last twelve months to 9.25B, up 0.28% year-over-year. In the year 2024, Jianzhijia Pharmaceutical Chain Group had annual revenue of 9.28B with 2.23% growth.
Revenue (ttm)
9.25B
Revenue Growth
+0.28%
P/S Ratio
0.33
Revenue / Employee
525.07K
Employees
17,625
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.28B | 202.15M | 2.23% |
| Dec 31, 2023 | 9.08B | 1.57B | 20.84% |
| Dec 31, 2022 | 7.51B | 2.28B | 43.54% |
| Dec 31, 2021 | 5.23B | 768.60M | 17.21% |
| Dec 31, 2020 | 4.47B | 937.83M | 26.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |